Welcome to the CJU website » LOG IN


Considerations of multigene test findings among men with prostate cancer - knowns and unknowns
1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA
Oct 2019 (Vol. 26, Issue 52, Pages( 14 - 16)
PMID: 31629418


Text-Size + 

  • Germline genetic testing has become an increasingly informative tool in the management of cancer patients. Over the past few years, the landscape of germline testing of prostate cancer patients has evolved significantly with the introduction of several multi-gene panel tests. Here, we dissect the clinically available prostate cancer-specific multi-gene panels and explore their performance on clinical series of prostate cancer patients from different ethnic groups.

Current Issue

August 2020, Vol.27 No.4
canadian journal of urology